{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:24:14Z","timestamp":1787502254269,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,2]],"date-time":"2017-01-02T00:00:00Z","timestamp":1483315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00066-016-1092-7","type":"journal-article","created":{"date-parts":[[2017,1,2]],"date-time":"2017-01-02T03:50:23Z","timestamp":1483329023000},"page":"276-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of postoperative radiotherapy in the management of malignant pleural mesothelioma","Bedeutung der postoperativen Strahlentherapie bei der Behandlung des malignen Pleuramesothelioms"],"prefix":"10.1007","volume":"193","author":[{"given":"Omar","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,2]]},"reference":[{"key":"1092_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.05.001","author":"V Panou","year":"2015","unstructured":"Panou V, Vyberg M, Weinreich U, Meristoudis C, Falkmer U, R\u00f8e O (2015) The established and future biomarkers of malignant pleural mesothelioma. Cancer Treat Rev. doi: 10.1016\/j.ctrv.2015.05.001","journal-title":"Cancer Treat Rev"},{"issue":"9564","key":"1092_CR2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(07)60412-7","volume":"369","author":"RT Lin","year":"2007","unstructured":"Lin RT, Takahashi K, Karjalainen A, Hoshuyama T, Wilson D, Kameda T et al (2007) Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet 369(9564):844\u2013849","journal-title":"Lancet"},{"issue":"5","key":"1092_CR3","first-page":"2493","volume":"35","author":"C Blomberg","year":"2015","unstructured":"Blomberg C, Nilsson J, Holgersson G, Edlund P, Bergqvist M, Adwall L et al (2015) Randomized trials of systemic medically-treated malignant mesothelioma: A\u00a0systematic review. Anticancer Res 35(5):2493\u20132501","journal-title":"Anticancer Res"},{"issue":"135","key":"1092_CR4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09059180.00007014","volume":"24","author":"OD R\u00f8e","year":"2015","unstructured":"R\u00f8e OD, Stella GM (2015) Malignant pleural mesothelioma: history, controversy and future of a\u00a0manmade epidemic. Eur Respir Rev 24(135):115\u2013131","journal-title":"Eur Respir Rev"},{"issue":"1","key":"1092_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tranon.2014.12.002","volume":"8","author":"J Faig","year":"2015","unstructured":"Faig J, Howard S, Levine EA, Casselman G, Hesdorffer M, Ohar JA (2015) Changing pattern in malignant mesothelioma survival. Transl Oncol 8(1):35\u201339","journal-title":"Transl Oncol"},{"issue":"6","key":"1092_CR6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.humpath.2015.02.006","volume":"46","author":"B Davidson","year":"2015","unstructured":"Davidson B (2015) Prognostic factors in malignant pleural mesothelioma. Hum Pathol 46(6):789\u2013804","journal-title":"Hum Pathol"},{"issue":"9483","key":"1092_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366(9483):397\u2013408","journal-title":"Lancet"},{"issue":"3","key":"1092_CR8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P et\u00a0al (2010) Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 35(3):479\u2013495","journal-title":"Eur. Respir. J."},{"key":"1092_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13014-015-0575-5","volume":"10","author":"C Thieke","year":"2015","unstructured":"Thieke C, Nicolay NH, Sterzing F, Hoffmann H, Roeder F, Safi S et al (2015) Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy. Radiat Oncol 10:267","journal-title":"Radiat Oncol"},{"issue":"14","key":"1092_CR10","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P et\u00a0al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J\u00a0Clin Oncol 21(14):2636\u20132644","journal-title":"J. Clin. Oncol."},{"key":"1092_CR11","doi-asserted-by":"publisher","DOI":"10.1586\/17476348.2015.1083426","author":"O Abdel-Rahman","year":"2015","unstructured":"Abdel-Rahman O, Kelany M (2015) Systemic therapy options for malignant pleural mesothelioma beyond first line therapy. Expert Rev Respir Med. doi: 10.1586\/17476348.2015.1083426","journal-title":"Expert Rev Respir Med"},{"issue":"2","key":"1092_CR12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","volume":"99","author":"E Taioli","year":"2015","unstructured":"Taioli E, Wolf AS, Flores RM (2015) Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg 99(2):472\u2013480","journal-title":"Ann. Thorac. Surg."},{"issue":"15","key":"1092_CR13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353(15):1591\u20131603","journal-title":"N. Engl. J. Med."},{"key":"1092_CR14","unstructured":"Surveillance, Epidemiology and End Results Program. About the SEER Program. Available at: http:\/\/seer.cancer.gov\/about . Accessed 25 June 2016"},{"issue":"1","key":"1092_CR15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41\u201355","journal-title":"Biometrika"},{"issue":"1","key":"1092_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","volume":"39","author":"PR Rosenbaum","year":"1985","unstructured":"Rosenbaum PR, Rubin DB (1985) Constructing a\u00a0control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 39(1):33\u201338","journal-title":"Am Stat"},{"issue":"3","key":"1092_CR17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46(3):399\u2013424","journal-title":"Multivariate Behav Res"},{"issue":"10","key":"1092_CR18","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/JTO.0b013e3181f1903e","volume":"5","author":"RM Flores","year":"2010","unstructured":"Flores RM, Riedel E, Donington JS, Alago W, Ihekweazu U, Krug L et al (2010) Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a\u00a0community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol 5(10):1649\u20131654","journal-title":"J Thorac Oncol"},{"key":"1092_CR19","first-page":"CD003880","volume":"3","author":"E Chapman","year":"2006","unstructured":"Chapman E, Berenstein EG, Dieguez M, Ortiz Z (2006) Radiotherapy for malignant pleural mesothelioma. Cochrane Database Syst Rev 3:CD003880","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1092_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1510\/icvts.2011.267252","volume":"13","author":"M Nagendran","year":"2011","unstructured":"Nagendran M, Pallis A, Patel K, Scarci M (2011) Should all patients who have mesothelioma diagnosed by video-assisted thoracoscopic surgery have their intervention sites irradiated? Interact Cardiovasc Thorac Surg 13(1):66\u201369","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"8","key":"1092_CR21","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1470-2045(16)30095-X","volume":"17","author":"AO Clive","year":"2016","unstructured":"Clive AO, Taylor H, Dobson L, Wilson P, de Winton E, Panakis N et al (2016) Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a\u00a0multicentre, open-label, phase 3, randomised controlled trial. Lancet Oncol 17(8):1094-1104","journal-title":"Lancet Oncol"},{"issue":"8","key":"1092_CR22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J et al (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12(8):763\u2013772","journal-title":"Lancet Oncol"},{"issue":"16","key":"1092_CR23","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","volume":"16","author":"RA Stahel","year":"2015","unstructured":"Stahel RA, Riesterer O, Xyrafas A, Opitz I, Beyeler M, Ochsenbein A et\u00a0al (2015) Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a\u00a0randomised, international, multicentre phase 2 trial. Lancet Oncol 16(16):1651\u20131658","journal-title":"Lancet Oncol"},{"issue":"2","key":"1092_CR24","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(16)00024-3","volume":"17","author":"A Rimner","year":"2016","unstructured":"Rimner A, Simone CB 2nd, Zauderer MG, Cengel KA, Rusch VW (2016) Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power? Lancet Oncol 17(2):e43\u2013e44","journal-title":"Lancet Oncol"},{"issue":"1","key":"1092_CR25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","volume":"196","author":"RR Meyerhoff","year":"2015","unstructured":"Meyerhoff RR, Yang CF, Speicher PJ, Gulack BC, Hartwig MG, D\u2019Amico TA et\u00a0al (2015) Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. J\u00a0Surg Res 196(1):23\u201332","journal-title":"J. Surg. Res."},{"issue":"12","key":"1092_CR26","doi-asserted-by":"crossref","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","volume":"10","author":"E Taioli","year":"2015","unstructured":"Taioli E, Wolf AS, Camacho-Rivera M, Kaufman A, Lee D\u2011S, Nicastri D et al (2015) Determinants of survival in malignant pleural mesothelioma: A\u00a0Surveillance, Epidemiology, and End Results (SEER) study of 14,228 patients. PLOS ONE 10(12):e0145039","journal-title":"PLOS ONE"},{"issue":"3","key":"1092_CR27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijrobp.2015.06.029","volume":"93","author":"E Minatel","year":"2015","unstructured":"Minatel E, Trovo M, Bearz A, Di Maso M, Baresic T, Drigo A et al (2015) Radical radiation therapy after lung-sparing surgery for malignant pleural mesothelioma: survival, pattern of failure, and prognostic factors. Int J Radiat Oncol Biol Phys 93(3):606\u2013613","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-016-1092-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-016-1092-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-016-1092-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T10:27:36Z","timestamp":1718965656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-016-1092-7"}},"subtitle":["A\u00a0propensity score matching of the SEER database","\u201ePropensity score matching\u201c der SEER-Datenbank"],"short-title":[],"issued":{"date-parts":[[2017,1,2]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1007\/s00066-016-1092-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727329786.793551911","asserted-by":"object"}]},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,2]]}}}